179 related articles for article (PubMed ID: 36192408)
1. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients.
Stürznickel J; Behler-Janbeck F; Baranowsky A; Schmidt T; Schwinge D; John C; Lohse AW; Schramm C; Heeren J; Schinke T; Amling M
Sci Rep; 2022 Oct; 12(1):16491. PubMed ID: 36192408
[TBL] [Abstract][Full Text] [Related]
2. Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.
Schmidt T; Schwinge D; Rolvien T; Jeschke A; Schmidt C; Neven M; Butscheidt S; Kriz M; Kunzmann L; Mussawy H; Hubert J; Hawellek T; Rüther W; Oheim R; Barvencik F; Lohse AW; Schramm C; Schinke T; Amling M
J Hepatol; 2019 May; 70(5):941-953. PubMed ID: 30641095
[TBL] [Abstract][Full Text] [Related]
3. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
Hirschfield GM; Chazouillères O; Drenth JP; Thorburn D; Harrison SA; Landis CS; Mayo MJ; Muir AJ; Trotter JF; Leeming DJ; Karsdal MA; Jaros MJ; Ling L; Kim KH; Rossi SJ; Somaratne RM; DePaoli AM; Beuers U
J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
[TBL] [Abstract][Full Text] [Related]
4. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
Voigtländer T; Wlecke J; Negm AA; Lenzen H; Manns MP; Lankisch TO
J Clin Gastroenterol; 2014; 48(10):866-9. PubMed ID: 24440929
[TBL] [Abstract][Full Text] [Related]
5. A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.
Gindin Y; Chung C; Jiang Z; Zhou JZ; Xu J; Billin AN; Myers RP; Goodman Z; Landi A; Houghton M; Green RM; Levy C; Kowdley KV; Bowlus CL; Muir AJ; Trauner M
Hepatology; 2021 Mar; 73(3):1105-1116. PubMed ID: 32745270
[TBL] [Abstract][Full Text] [Related]
6. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
7. In vivo
Mohajeri S; Bezabeh T; Ijare OB; King SB; Thomas MA; Minuk G; Lipschitz J; Kirkpatrick I; Micflikier AB; Summers R; Smith ICP
NMR Biomed; 2019 May; 32(5):e4065. PubMed ID: 30735273
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.
Ghonem NS; Auclair AM; Hemme CL; Gallucci GM; de la Rosa Rodriguez R; Boyer JL; Assis DN
Clin Pharmacol Ther; 2020 Dec; 108(6):1213-1223. PubMed ID: 32480421
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
10. Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis.
Braadland PR; Schneider KM; Bergquist A; Molinaro A; Lövgren-Sandblom A; Henricsson M; Karlsen TH; Vesterhus M; Trautwein C; Hov JR; Marschall HU
JHEP Rep; 2022 Nov; 4(11):100561. PubMed ID: 36176935
[TBL] [Abstract][Full Text] [Related]
11. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
[TBL] [Abstract][Full Text] [Related]
13. Bile proteome analysis by high-precision mass spectrometry to examine novel biomarkers of primary sclerosing cholangitis.
Kan M; Chiba T; Konno R; Kouchi Y; Mishima T; Kawashima Y; Kishimoto T; Ohtsuka M; Ohara O; Kato N
J Hepatobiliary Pancreat Sci; 2023 Jul; 30(7):914-923. PubMed ID: 36528781
[TBL] [Abstract][Full Text] [Related]
14. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Gui W; Hole MJ; Molinaro A; Edlund K; Jørgensen KK; Su H; Begher-Tibbe B; Gaßler N; Schneider CV; Muthukumarasamy U; Mohs A; Liao L; Jaeger J; Mertens CJ; Bergheim I; Strowig T; Hengstler JG; Hov JR; Marschall HU; Trautwein C; Schneider KM
Nat Commun; 2023 Jun; 14(1):3304. PubMed ID: 37280200
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
Tietz-Bogert PS; Kim M; Cheung A; Tabibian JH; Heimbach JK; Rosen CB; Nandakumar M; Lazaridis KN; LaRusso NF; Sung J; O'Hara SP
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332763
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of primary sclerosing cholangitis.
Yimam KK; Bowlus CL
Autoimmun Rev; 2014; 13(4-5):445-50. PubMed ID: 24424180
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
Gauss A; Sauer P; Stiehl A; Rupp C; Krisam J; Leopold Y; Kloeters-Plachky P; Stremmel W; Gotthardt D
Medicine (Baltimore); 2016 Apr; 95(17):e3510. PubMed ID: 27124059
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
19. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic and surgical management of primary sclerosing cholangitis.
Michaels A; Levy C
Medscape J Med; 2008; 10(10):242. PubMed ID: 19099036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
